Health AI Central
Share:
Peer-Reviewed Publication
J Med Internet Res2021;23(3):e17908.March 25, 2021Journal Article

Evaluating Glycemic Control in Patients of South Asian Origin With Type 2 Diabetes Using a Digital Therapeutic Platform: Analysis of Real-World Data.

Arjun Krishnakumar1, Ritika Verma1, Rajeev Chawla2, Aravind Sosale3, Banshi Saboo4, Shilpa Joshi1, Maaz Shaikh1, Abhishek Shah1, Siddhesh Kolwankar1, Vinod Mattoo1
1Wellthy Therapeutics Pvt Ltd, Mumbai, India.
2Department of Diabetology, North Delhi Diabetes Centre, New Delhi, India.
3Department of Diabetology, Diacon Hospital, Bengaluru, India.
4Department of Diabetology, Dia Care-Diabetes Care and Hormone Clinic, Ahmedabad, India.
PubMed PMC DOI PDF

Abstract

BACKGROUND: Digital therapeutics are evidence-based therapeutic interventions driven by high-quality software programs for the treatment, prevention, or management of a medical disorder or disease. Many studies in the western population have shown the effectiveness of mobile app-based digital therapeutics for improving glycemic control in patients with type 2 diabetes (T2D). However, few studies h…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.